Janssen Search
Search results
Partner With Johnson & Johnson Innovation Centers
Partner With Johnson & Johnson Innovation Johnson & Johnson Innovation identifies the best opportunities for value-generating collaborations, while cultivating a strong network of experts. With regional centers in Boston, Massachusetts; San ...
Partner with Johnson & Johnson Innovation
Article Type: Disease Interception Accelerator Partner with Johnson & Johnson Innovation Johnson & Johnson Innovation identifies the best opportunities for value-generating collaborations, while cultivating a strong network of experts. With ...
Johnson & Johnson Executive Vice President, William N. Hait, M.D., Ph.D., to Retire, Effective September 2024
May 30, 2024 NEW BRUNSWICK, N.J., May 30, 2024 – Johnson & Johnson (NYSE: JNJ) today announced William N. (Bill) Hait, M.D., Ph.D., will retire from his position as Executive Vice President, Chief External Innovation and Medical Officer, in September ...
Ben Wiegand, Ph.D.
BEN WIEGAND, PH.D. GLOBAL HEAD WORLD WITHOUT DISEASE ACCELERATOR As Global Head of the World Without Disease Accelerator (WWDA), Ben Wiegand, Ph.D. leads a team focused on catalyzing a paradigm shift from disease care to health care through novel ...
Johnson & Johnson Marks New Era as Global Healthcare Company with Updated Visual Identity
Sep 14, 2023 United States Brand and visual identity demonstrate the best of Johnson & Johnson’s care and humanity, while capturing the Company’s passion and determination to improve the health of people worldwide New Brunswick, N.J., Sept. 14, 2023 ...
Jennifer L. Taubert
JENNIFER L. TAUBERT EXECUTIVE VICE PRESIDENT WORLDWIDE CHAIRMAN, INNOVATIVE MEDICINE JOHNSON & JOHNSON Jennifer L. Taubert is Executive Vice President and Worldwide Chairman, Innovative Medicine at Johnson & Johnson, the world’s largest healthcare ...
Darren Snellgrove
DARREN SNELLGROVE VICE PRESIDENT GROUP FINANCE WORLDWIDE PHARMACEUTICALS Darren Snellgrove is Vice President, Group Finance, Worldwide Pharmaceuticals. In this position, Darren will provide strategic and financial leadership to the Global Pharmaceuticals ...
Carcinogenic Exposure Meter QuickFire Challenge
Carcinogenic Exposure Meter QuickFire Challenge Janssen Research & Development, LLC and Johnson & Johnson Innovation, JLABS launched the Carcinogenic Exposure Meter QuickFire Challenge, aimed to help foster innovation that can measure the impact ...
Guy Seabrook, Ph.D.
GUY SEABROOK, PH.D. HEAD OF EXTERNAL INNOVATION As Head of External Innovation for Neuroscience, Guy Seabrook, Ph.D. creates and implements the external innovation plan to deliver the Neuroscience Therapeutic Area Research & Development strategy. Guy ...
ASCO/EHA 2022
Welcome to the Janssen Oncology ASCO Virtual Newsroom Peter Lebowitz, M.D., Ph.D. Global Therapeutic Area Head Oncology Janssen Research & Development, LLC Tyrone Brewer U.S. President Oncology Janssen Biotech, Inc. Strength in Numbers: How Data ...